Cases & Deals

CARMAT takes out €50 million equity line with Kepler Cheuvreux

Clients CARMAT SA

Jones Day advised CARMAT SA, a developer of heart prosthesis, in connection with a €50 million (US$57.7 million) equity line with Kepler Cheuvreux.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.